What is POTS and why is it more common now?
The amount of circulation disorder cases has tripled


Since the Covid-19 pandemic, there has been a rise in cases of postural orthostatic tachycardia syndrome (POTS). The circulation disorder mostly affects women, and while cases used to appear in older individuals, doctors are now seeing a rise in patients between the ages of 15 and 25. POTS can be debilitating and does not currently have a cure.
What is POTS?
POTS is a "condition that causes a number of symptoms when you transition from lying down to standing up, such as a fast heart rate, dizziness and fatigue," said The Cleveland Clinic. Reason being, "when you've got POTS and stand up, more blood than normal pools down in the lower half of your body," said Forbes. This causes your heart to beat faster to compensate. The condition affected between one and three million people prior to the pandemic, but a pre-printed study by Johns Hopkins said that instances have more than tripled, with approximately 6 to 7 million new cases. "The most common trigger of POTS is a viral infection," Svetlana Blitshteyn, a neurologist and the director of the Dysautonomia Clinic in Buffalo, New York, said to CBS News. "This includes viruses like influenza and parvovirus and Covid-19."
There has been a recent slew of diagnoses in teens and adults who were otherwise healthy. Specifically, highly-trained female athletes have been affected. "These patients are young people in their 20s, 30s and 40s who were healthy or had minor medical problems that didn't impact their lives before and now they are expressing extreme fatigue, dizziness, headache, inability to exercise and some are unable to work," Blitshteyn said. However, doctors are not quick to diagnose POTS. "Since POTS isn't technically life-threatening, if you're fatigued or fainting, have a racing heartbeat, a doc will likely scan you for other, perhaps more immediately dangerous, things before considering POTS," said Self.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Who is most affected?
Anyone can get POTS, but it is "primarily seen in women that are of reproductive age," said The University of Utah. The reason for this is not yet clear, but some conditions associated with POTS also primarily affect women, like hypermobile Ehlers-Danlos syndrome and autoimmune diseases. Women are also thought to be "more vulnerable to inflammation," said The Washington Post. "It could reflect the damage that comes with being hit with a virus unknown to humans until 2020. And the stress associated with repetitive physical exhaustion could leave athletes at risk."
Athletes may be predisposed to the condition. Some of those diagnosed also had hypermobility, meaning they have a greater-than-average range of motion, which is beneficial in a number of sports. But hypermobility could also be making blood vessels "more stretchy," impacting heart rate and blood pressure, Sara Gould, an orthopedic surgeon, said to the Post. In addition, some POTS patients also have a "condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is characterized by post-exertional malaise (PEM) — a situation in which symptoms worsen after exercise," said National Geographic.
The severity of POTS can vary greatly from person to person. "Patients with severe symptoms might have to limit their lifestyles and daily activities a great deal, to the point where they can't work a full-time job that involves a lot of standing or walking," said Richard Shelton, a cardiologist at the University of Utah Health. However, for many, symptoms are manageable through exercise, diet changes, sleep changes, and in some cases, medication.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Today's political cartoons - March 29, 2025
Cartoons Saturday's cartoons - my way or Norway, running orders, and more
By The Week US Published
-
5 tactically sound cartoons about the leaked Signal chat
Cartoons Artists take on the clown signal, baby steps, and more
By The Week US Published
-
Roast lamb shoulder with ginger and fresh turmeric recipe
The Week Recommends Succulent and tender and falls off the bone with ease
By The Week UK Published
-
MAHA moms: the cohort of women backing RFK Jr.'s health agenda
The Explainer America's head health honcho has a flock of supporters spreading the MAHA message on social media
By Theara Coleman, The Week US Published
-
Five years on: How Covid changed everything
Feature We seem to have collectively forgotten Covid’s horrors, but they have completely reshaped politics
By The Week US Published
-
Why women are most at risk in Africa's obesity crisis
Under the Radar Stigma and lack of access to medication draws comparisons with HIV epidemic
By Harriet Marsden, The Week UK Published
-
Health care is full of cognitive biases. Some think AI can help.
The Explainer Humans are fallible but technology can be, too
By Devika Rao, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
IVM is a better treatment than IVF for some women
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
The decline of the contraceptive pill
In the Spotlight Fears of the pill's side effects, stoked by social media, behind switch to fertility trackers – or no contraception at all
By Harriet Marsden, The Week UK Published